Work-related risks for bile duct and pancreatic cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how certain jobs or work environments may affect the risk of getting bile duct or pancreatic cancers. It compares work histories of people who have these cancers with those who do not, to see if certain exposures at work might be linked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been part of a specific study (TEDOPAM or IMMUNOBIL) if you have bile duct or pancreatic cancer.
- Your complete work history must be available and clear.
- If you are in the comparison group, you must be at least 18 years old and have no bile duct or pancreatic cancer.
- You cannot have a known family history of these cancers.
- You must agree to allow your existing data to be used for this research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at factors in the family and the environment that may be linked to pancreatic cancer. It includes people with pancreatic cancer and several types of pancreas-related conditions, as well as some healthy volunteers, and may help researchers understand who is at higher risk.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
This study uses a blood test to look at how your immune system responds, which may help tell if chronic pancreatitis could turn into pancreatic cancer. It aims to find better ways to monitor people with chronic pancreatitis and catch cancer earlier.
This study looks at blood markers and gut bacteria to better understand the risk of pancreatic cancer in people with chronic pancreatitis (long-term pancreas inflammation). It may help detect cancer earlier or guide prevention.
Hear when a new Biliary Tract Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.